Two Sigma Investments, LP Myriad Genetics Inc Transaction History

Two Sigma Investments, LP

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$17.59 - $23.59 $295,512 - $396,312	-16,800 Reduced 45.16%	20,400 $434,000
Q4 2023 Feb 14, 2024	BUY	$13.91 - $21.32 $38,948 - $59,696	2,800 Added 8.14%	37,200 $712,000
Q3 2023 Nov 14, 2023	BUY	$15.99 - $23.22 $67,158 - $97,524	4,200 Added 13.91%	34,400 $551,000
Q2 2023 Aug 14, 2023	BUY	$17.56 - $23.76 $230,035 - $311,256	13,100 Added 76.61%	30,200 $700,000
Q1 2023 May 15, 2023	SELL	$15.26 - $23.75 $147,106 - $228,950	-9,640 Reduced 36.05%	17,100 $397,000
Q4 2022 Feb 14, 2023	BUY	$14.51 - $20.99 $387,997 - $561,272	26,740 New	26,740 $387,000
Q3 2021 Nov 15, 2021	SELL	$29.97 - $36.66 $2.59 Million - $3.16 Million	-86,256 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$25.39 - $32.61 $6.9 Million - $8.86 Million	-271,667 Reduced 75.9%	86,256 $2.64 Million
Q1 2021 May 17, 2021	SELL	$19.92 - $31.6 $4.96 Million - $7.87 Million	-249,170 Reduced 41.04%	357,923 $10.9 Million
Q4 2020 Feb 16, 2021	SELL	$12.16 - $19.77 $4.48 Million - $7.28 Million	-368,327 Reduced 37.76%	607,093 $12 Million
Q3 2020 Nov 16, 2020	BUY	$11.25 - $14.75 $2.51 Million - $3.29 Million	222,831 Added 29.61%	975,420 $12.7 Million
Q2 2020 Aug 14, 2020	BUY	$10.69 - $16.49 $6.78 Million - $10.5 Million	633,786 Added 533.48%	752,589 $8.53 Million
Q1 2020 May 15, 2020	BUY	$9.78 - $29.53 $1.03 Million - $3.1 Million	104,917 Added 755.56%	118,803 $1.7 Million
Q4 2019 Feb 14, 2020	BUY	$20.93 - $35.1 $290,633 - $487,398	13,886 New	13,886 $378,000

253

90.5M

100K

34K

Ticker MYGN
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 80,634,800
Market Cap $1.11B
Description
Myriad Genetics, Inc., a genetic testing and precision medicine company, develops and commercializes genetic tests in the United States and internationally. The company offers molecular diagnostic tests for use in oncology, and women's and mental health applications. It provides MyRisk Hereditary Cancer Test, a DNA sequencing test for assessing ...

Get notified when there are updates to the investment portfolio of Two Sigma Investments, LP, based on Form 13F filings with the SEC.

Stay updated on Two Sigma Investments, LP with notifications on news.